The zymography assay revealed the presence of different molecular forms of MMP-2 and MMP-9 with the capacity to degrade gelatin; the activity of both enzymes was augmented in most lung cancer patients (Figures 2(b)–2(f)) in comparison with control samples (Figure 2(a)). The gene discussed is MMP9; the disease is lung carcinoma.